Department of Medicine Archives
NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID
Feb. 22, 2024—Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.
Feb. 22, 2024—John H. Newman, MD, an acclaimed physician-scientist in Vanderbilt University Medical Center’s Division of Allergy, Pulmonary and Critical Care Medicine who made numerous contributions to the knowledge of pulmonary vascular disease, died on Tuesday, Feb. 20, after a several-month illness. He was 78.
Feb. 21, 2024—An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.
Feb. 20, 2024—In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.
Feb. 20, 2024—Vanderbilt's Ashley Spann, MD, MSACI, is the inaugural recipient of the Harold Amos Medical Faculty Development Program Hepatology Award from the American Association for the Study of Liver Diseases.
Feb. 19, 2024—An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.
Feb. 15, 2024—Timothy Blackwell, MD, director of the Division of Allergy, Pulmonary and Critical Care Medicine, is leaving Vanderbilt University Medical Center to chair the Department of Internal Medicine at the University of Michigan.
Feb. 15, 2024—Katherine Hartmann, MD, PhD, and Sunil Kripalani, MD, MSc, were honored for their service to translational scientists at Vanderbilt University Medical Center during the Vanderbilt Translational Research Forum.
Feb. 7, 2024—Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.
Feb. 2, 2024—A multicenter, longitudinal study, co-led by investigators at the Vanderbilt Diabetes Research and Training Center, has discovered that a small pancreas size predicts a faster progression to stage 3 Type 1 diabetes (T1D), the point at which clinical diagnosis occurs.
Jan. 31, 2024—The Vanderbilt Transplant Center established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.